SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Grove Biopharma to Participate in Materials Biology Symposium at ACS Fall 2025 Scientific Meeting
August 18, 2025
 · 
2 min read
Press Releases
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
August 18, 2025
 · 
3 min read
Press Releases
Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP)
August 18, 2025
 · 
4 min read
Press Releases
Ascelia Pharma Updates Timeline for Submission of the Orviglance NDA
August 18, 2025
 · 
1 min read
Press Releases
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
August 18, 2025
 · 
15 min read
Press Releases
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
August 18, 2025
 · 
3 min read
Press Releases
4DMT Announces New Employment Inducement Grants - August 15, 2025
August 18, 2025
 · 
2 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
 · 
3 min read
Press Releases
Children’s Hospital of Philadelphia and Children’s Hospital Colorado Researchers Conduct First Prospective Study of Pediatric EoE Patients and Disease Progression
August 18, 2025
 · 
5 min read
Press Releases
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
August 18, 2025
 · 
4 min read
Press Releases
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
August 18, 2025
 · 
13 min read
Press Releases
Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH
August 18, 2025
 · 
4 min read
Press Releases
Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors
August 18, 2025
 · 
4 min read
Press Releases
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
August 18, 2025
 · 
15 min read
Press Releases
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
August 18, 2025
 · 
1 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
 · 
3 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
 · 
1 min read
Press Releases
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
 · 
3 min read
Press Releases
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
August 18, 2025
 · 
11 min read
Press Releases
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity
August 18, 2025
 · 
3 min read
Press Releases
Gabby Thomas Partners with Babson Diagnostics’ BetterWay to Promote Accessible Healthcare
Olympic Gold Medalist and Public Health Advocate to Raise Awareness for Routine Blood Testing
August 15, 2025
 · 
1 min read
Press Releases
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
August 15, 2025
 · 
2 min read
Press Releases
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
August 15, 2025
 · 
11 min read
Press Releases
Novel Gene Therapy for ALS cleared for global trials in China and the U.S.
August 15, 2025
 · 
4 min read
Press Releases
Enlivex Announces Positive Topline Data From Multi-Country, Randomized, Controlled, Phase I/II Trial Evaluating Allocetra in Patients With Moderate-To-Severe Knee Osteoarthritis
August 19, 2025
 · 
6 min read
Press Releases
Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases
August 19, 2025
 · 
7 min read
Press Releases
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
August 19, 2025
 · 
8 min read
Press Releases
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
August 19, 2025
 · 
15 min read
Press Releases
Aptose Reports Early Data Demonstrating Tuspetinib Improves Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML in Phase 1/2 TUSCANY Trial
August 19, 2025
 · 
8 min read
Press Releases
FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet’s Disease after Reviewing Recent Phase 2 Clinical Study Results
August 19, 2025
 · 
12 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 19, 2025
 · 
17 min read
Press Releases
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
August 19, 2025
 · 
6 min read
Press Releases
LIXTE Biotechnology Holdings Provides Corporate Update
August 19, 2025
 · 
6 min read
Press Releases
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
August 19, 2025
 · 
5 min read
Load More